bioAffinity Technologies, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
bioAffinity Technologies, Inc. (BIAF) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $130.39 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-07
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $130.39K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $103.53K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $39.04K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $45.69K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $130.39K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $103.53K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $39.04K 10-K · filed 2026-03-16 |
| 2025-09-30 | $45.69K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $52.98K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $60.87K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $69.37K 10-K · filed 2025-03-31 |
| 2024-09-30 | $78.46K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $44.02K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $51.01K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $58.48K 10-K · filed 2024-04-01 |
| 2023-09-30 | $66.36K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |